Medicines in developMent Biologics

factor (EGFR) that is linked to the growth and development of many types of cancer. Originally the mAb was approved for the treatment of EGFR-expressing metastatic colorectal cancer. Additional studies have found that the presence or absence of a certain gene mutation could predict the patients’ response to treatment. Patients without the gene ................
................